Assessment of platelet indices and their interpretation in thrombocytopenia
DOI:
https://doi.org/10.61841/n5qzyf25Keywords:
platelet, platelet distribution width, thrombocytopeniaAbstract
condition in hospitalized patients, may go unnoticed. The present study was conducted to assess platelet indices and their interpretation in thrombocytopenia.
Materials & Methods: 58 patients of thrombocytopenia of both genders were put in group I and controls in group II. Group I was further divided into group A – as accelerated destruction and b- as impaired production. The laboratory used a 5-part automated hematology analyzer to process all patient blood samples that were received in K3-EDTA anticoagulated vacutainers within an hour of collection. (Horiba Medical, Pentra ES 60) Platelet count and platelet parameters, such as mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR), and platelet crit (PCT), were recorded from the analyzer-generated reports.
Results: Group I had 38 males and 20 females and group II had 29 each male and female. In group A, B and II, mean platelets count (x 109/L) was 106.2, 75.2 and 254.8, PDW (fL) was 19.5, 17.1 and 16.3, MPV (fL) was 13.7, 13.2 and 12.3, P- LCR (%) was 54.2, 42.7 and 40.9 and PCT (%) was 0.09, 0.03 and 0.21 respectively. The difference was significant (P<0.05).
Conclusion: PCT and platelet count are directly correlated, and platelet crit can be used to evaluate both quantitative and qualitative platelet problems. The mechanism underlying the low platelet count can be deciphered using additional parameters such as PDW, PLCR, and MPV in addition to PCT. High index values suggest a greater breakdown of platelets in the bloodstream, while low values may be the result of impaired production brought on by primary or secondary bone marrow disease.
Downloads
References
1. James Bussel, Douglas Cines. Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia. In: Ronald Hoffman, Edward J, eds. Hematology: Basic Principles and Practices. 4th ed. London: Churchill Livingstone; 2005: 1321- 1353.
2. Theodore E, John G. Kelton. Thrombocytopenia due to platelet destruction & hypersplenism. In: Ronald Hoffman, Edward J, eds. Hematology: Basic Principles and Practices. 4th ed. London: Churchill Livingstone; 2005: 1225-1267.
3. Osselaer J, Scheiff J. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem. 1997;43(6):1072-6.
4. Amar S, Sanjay N. Role of platelet parameters in diagnosing various clinical conditions. Natl J Med Res. 2005;3:162-5.
5. Brummitt DR, Barker HF. The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser. Clin Lab Haematol. 2000;22:103-7.
6. Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement,EDTA or citrate.Hematology. 2006;11: 317-9.
7. Park Y, SchoeneN, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002;13:301–6.
8. Bancroft AJ, Abel EW, McLaren M, Belch JJ, Mean platelet volume is a useful parameter: A reproducible routine method using a modified Coulter thrombocytometer. Platelets 2000; 379-87.
9. Baynes RD, Lamparelli RD, Bezwoda WR, Gear AJ, Chetty N, Atkinson P, Platelet parameters. Part II. Platelet volume-number relationships in various normal and disease states South Afr Med J 1988; 73(1):39-43.
10. Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol. 2005;27:370-3.
11. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune Thrombocytopenia. Br J Haematol 2005; 128:698-702.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
